Metabolic-Fit / 100
NovoCare Pharmacy review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
The manufacturer's own channel for brand Wegovy — self-pay from $149/mo for the 1.5 mg pill ($199 at 4 mg, $349 for the pen, $399 for the 7.2 mg HD pen) or as low as $25/mo with commercial insurance — but it requires your own existing prescription and offers no tirzepatide, since that's a different company's drug.
From $149/mo self-pay (Wegovy pill, 1.5 mg)
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
NovoCare Pharmacy at a glance
- Semaglutide
- From $149/mo self-pay (Wegovy pill, 1.5 mg)
- Tirzepatide
- Not offered — Novo Nordisk does not manufacture tirzepatide
- Coverage
- All 50 states
- Brand-name
- Yes
How we scored NovoCare Pharmacy
Every factor comes from NovoCare Pharmacy's own published pricing, disclosures and oversight, and the six combine into the 48/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Novo Nordisk's own pharmacy program for Wegovy — self-pay from $149 a month for the 1.5 mg pill ($199 at 4 mg), $349 for the pen and $399 for the 7.2 mg HD pen, or as little as $25 with commercial insurance. Two things set it apart from the telehealth sellers here: there is no tirzepatide, because Novo does not make it, and you need a prescription from your own doctor already in hand.
Before you sign up
What NovoCare Pharmacy's public site and signup page show before you hand over any details.
Worth knowing
- This is Novo Nordisk's own official pharmacy program for Wegovy — not a telehealth intake, but a savings-card and direct-fulfillment page
- The page shows self-pay and insurance-copay pricing directly, no account creation required to see a number
- A prescription from your own doctor is required; NovoCare Pharmacy (operated by CoAssist Pharmacy d/b/a NovoCare Pharmacy) fills it
- Genuinely the manufacturer's own channel — not a third-party telehealth intermediary — which is a real trust signal, though it also means there's no bundled consult; you need your own prescriber first
- Only FDA-approved brand Wegovy is offered here; Novo Nordisk does not make tirzepatide (that's Eli Lilly's molecule, sold as Mounjaro/Zepbound)
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS — it's a pharmacy fulfillment page, not a clinical program
Pricing
| Medication | Price | Plan |
|---|---|---|
| Brand semaglutide | $149 | Wegovy® pill 1.5 mg, self-payNovo Nordisk's own savings-offer page: $149 for each month of 1.5 mg (one bottle of 30 tablets), filled through NovoCare Pharmacy. Listed as a limited-time offer through December 31, 2026. |
| Brand semaglutide | $199 | Wegovy® pill 4 mg, self-pay$199 per month for 4 mg, per the same page. |
| Brand semaglutide | $299 | Wegovy® pill 9 mg or 25 mg, self-pay$299 per month for 9 mg and 25 mg, per the same page. |
| Brand semaglutide | $199 → $349 | Wegovy® pen 0.25–2.4 mg, self-pay$349 per month for any pen dose from 0.25 mg to 2.4 mg. New patients pay $199 for each of their first two monthly fills at 0.25 mg and 0.5 mg, through December 31, 2026. |
| Brand semaglutide | $399 | Wegovy® HD pen 7.2 mg, self-pay$399 per month for Wegovy HD (semaglutide 7.2 mg), per the same page. |
| Brand semaglutide | $25 | Wegovy® with commercial insuranceCapped at $100/month in savings via the manufacturer's own savings card; requires commercial insurance coverage for Wegovy. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what NovoCare Pharmacy's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- The manufacturer's own official pharmacy channel — a genuine trust signal, not a third-party intermediary
- As low as $25/month with commercial insurance via the savings card, capped at $100/month in savings
- Self-pay pricing is published dose by dose, from $149/mo for the 1.5 mg pill, with no account required to see it
- FDA-approved brand Wegovy, not a compounded formulation
The caveats
- Requires an existing prescription from your own doctor — no bundled consult or intake, unlike every telehealth provider on this list
- No tirzepatide offered — Novo Nordisk doesn't manufacture it
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS — it's a pharmacy fulfillment page, not a clinical program
- Self-pay prices rise with dose — $199 for the 4 mg pill, $349 for the pen, $399 for the 7.2 mg HD pen — and are listed as offers through December 31, 2026
This is a pharmacy route, not a care membership
NovoCare Pharmacy is Novo Nordisk's own channel for filling branded Wegovy prescriptions. It requires a prescription from your clinician; the advertised medication price does not buy a bundled telehealth consultation or ongoing weight-management membership. That distinction can make it useful for someone who already has a prescribing relationship. Someone still seeking an assessment needs to budget for and arrange that care separately, rather than assuming a pharmacy order replaces an individual medical evaluation.
Tirzepatide is not offered through this channel. Novo Nordisk manufactures semaglutide products, while Zepbound and Mounjaro are Eli Lilly products. The absence of tirzepatide is a product boundary, not a statement about which medicine suits a patient. Compare the exact prescribed brand, form, and dose with the route available to you. A pharmacy selling an approved brand should not be ranked against a service fee or a compounded formulation as though all three purchased the same thing.
The pill price changes with dose
The published self-pay Wegovy pill offer is $149 for a monthly supply at 1.5 mg, $199 at 4 mg, and $299 at 9 mg or 25 mg. The 1.5 mg offer describes a bottle of 30 tablets. The lowest figure therefore belongs to one dose, not an all-dose program. A clinician determines the appropriate prescription; choosing a dose to preserve a low price is not a substitute for following that prescription.
The self-pay Wegovy pen offer is $349 per month for doses from 0.25 through 2.4 mg, with a $199 new-patient price for the first two monthly fills at the specified 0.25 and 0.5 mg starting doses. Wegovy HD 7.2 mg is listed separately at $399. These product-specific offers should remain separate when estimating future spending. An introductory pen price cannot be carried over to every refill, and the pill's lowest figure is not the pen price.
Insurance savings have separate conditions
The manufacturer advertises a commercial-insurance savings card that can bring an eligible patient's payment as low as $25 per month, with savings capped at $100 per month. “As low as” is not a guaranteed copay for everyone. The prescription needs the relevant coverage and eligibility, and the savings limit can leave a different out-of-pocket amount. Confirm the actual pharmacy quote under your insurance rather than placing $25 beside an unconditional cash offer as though the terms were identical.
The published self-pay offers are described as running through December 31, 2026. That stated end date should stay visible when considering treatment beyond the offer period. Ask which price applies to the actual fill and what happens when an offer changes. A manufacturer's official pharmacy route provides a clear product source, but it does not guarantee that today's promotion will continue indefinitely or that another pharmacy and benefit arrangement will have the same price.
Keep the clinical relationship in place
Wegovy is an FDA-approved branded medicine, unlike a compounded product. Its approved labeling belongs to the particular product, and clinical questions still need to go to the prescriber. The pharmacy's role is fulfillment rather than a specialized postpartum or PCOS program. If pregnancy planning, breastfeeding, or other relevant circumstances change, discuss them with the clinician managing treatment instead of relying on a savings page to determine suitability or timing.
NovoCare is most straightforward for someone with an existing prescription who wants to understand manufacturer-direct fulfillment and dose-specific self-pay offers. Confirm delivery availability, refill timing, the exact product, and the final amount before ordering. Keep any outside appointment or management fee in your broader care budget. The useful advantage is a clearly identified branded supply route; the financial decision still depends on dose, form, insurance eligibility, and the limits of the current promotion.
The bottom line for mothers
Best for: Mothers who already have a Wegovy prescription and commercial insurance, and want the manufacturer's own savings program rather than a compounded alternative.
Alternatives to NovoCare Pharmacy
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Sesame81
Metabolic-Fit / 100
A real telehealth marketplace with a video visit and a clinician you pick — now brand-first, so you get on-label Wegovy or Zepbound with the manufacturer's own pregnancy labeling, if you can absorb a membership fee stacked on the drug price.
- Visit Wellorithm42
Metabolic-Fit / 100
Compounded GLP-1s as an injection or an oral dissolving tablet, plus brand pens from $899 a month on a 3-month plan, in 49 states — but compounded prices appear only after the assessment and no cancellation policy is published.
Providers like NovoCare Pharmacy
Keep comparing NovoCare Pharmacy
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
NovoCare Pharmacy, answered
- How much does NovoCare Pharmacy actually charge for Wegovy?
- Self-pay (no insurance) depends on the form and dose. The Wegovy pill is $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg or 25 mg. The pen is $349 a month at any dose up to 2.4 mg (new patients pay $199 for their first two fills at the starting doses), and the 7.2 mg Wegovy HD pen is $399. Novo lists these as offers through December 31, 2026. With commercial insurance, the manufacturer's savings card can bring your cost as low as $25/month, capped at $100/month in total savings.
- Does NovoCare Pharmacy offer tirzepatide?
- No. Novo Nordisk manufactures semaglutide (Ozempic, Wegovy), not tirzepatide — that molecule (Mounjaro, Zepbound) belongs to Eli Lilly. NovoCare Pharmacy is Novo Nordisk's own direct channel and only fills its own brand Wegovy prescriptions.
Pricing, states and verification reflect NovoCare Pharmacy's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.